Altimmune, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Altimmune, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Altimmune, Inc. Return On Equity for the quarter ending June 30, 2024 was -60.5 %, a 35% decline year-over-year.
  • Altimmune, Inc. annual Return On Equity for 2023 was -52 %, a 18.2% decline from 2022.
  • Altimmune, Inc. annual Return On Equity for 2022 was -44 %, a 1.57% decline from 2021.
  • Altimmune, Inc. annual Return On Equity for 2021 was -43.3 %, a 20.8% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -60.5 -15.7 -35% Apr 1, 2024 Jun 30, 2024
Q1 2024 -54.2 -8.79 -19.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52 -8.01 -18.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -46.8 -2.38 -5.36% Jul 1, 2023 Sep 30, 2023
Q2 2023 -44.8 +4.4 +8.94% Apr 1, 2023 Jun 30, 2023
Q1 2023 -45.4 +3.36 +6.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -44 -0.68 -1.57% Oct 1, 2022 Dec 31, 2022
Q3 2022 -44.4 -8.05 -22.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49.2 -19.4 -65.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.7 -16.8 -52.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -43.3 -7.47 -20.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -36.3 +10.1 +21.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -29.8 +36.2 +54.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -32 +14.3 +30.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -35.9 +3.14 +8.05% Oct 1, 2020 Dec 31, 2020
Q3 2020 -46.4 +30.4 +39.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -66 -2.43 -3.82% Apr 1, 2020 Jun 30, 2020
Q1 2020 -46.2 +37 +44.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -39 +56.3 +59.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -76.8 -16.3 -27% Jul 1, 2019 Sep 30, 2019
Q2 2019 -63.6 +60.5 +48.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -83.2 +4.75 +5.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -95.3 +0.73 +0.76% Oct 1, 2018 Dec 31, 2018
Q3 2018 -60.5 -147 -170% Jul 1, 2018 Sep 30, 2018
Q2 2018 -124 -220 -230% Apr 1, 2018 Jun 30, 2018
Q1 2018 -88 -208 -173% Jan 1, 2018 Mar 31, 2018
Q4 2017 -96.1 -231 -171% Oct 1, 2017 Dec 31, 2017
Q3 2017 86.4 +103 Jul 1, 2017 Sep 30, 2017
Q2 2017 95.5 +117 Apr 1, 2017 Jun 30, 2017
Q1 2017 120 +146 Jan 1, 2017 Mar 31, 2017
Q4 2016 135 +149 Oct 1, 2016 Dec 31, 2016
Q3 2016 -16.2 +9.82 +37.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -21.5 +22.1 +50.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -25.9 +11.2 +30.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -13.9 +57.8 +80.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -26 +79.3 +75.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -43.5 +73.3 +62.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -37.1 +80.9 +68.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -71.7 +40.3 +36% Oct 1, 2014 Dec 31, 2014
Q3 2014 -105 -31.2 -42% Jul 1, 2014 Sep 30, 2014
Q2 2014 -117 -76.1 -187% Apr 1, 2014 Jun 30, 2014
Q1 2014 -118 -81.5 -223% Jan 1, 2014 Mar 31, 2014
Q4 2013 -112 -73.8 -193% Oct 1, 2013 Dec 31, 2013
Q3 2013 -74.2 -53.3 -256% Jul 1, 2013 Sep 30, 2013
Q2 2013 -40.8 -21.9 -116% Apr 1, 2013 Jun 30, 2013
Q1 2013 -36.5 -6.25 -20.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -38.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -20.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -18.9 Mar 31, 2012 Jun 30, 2012
Q1 2012 -30.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.